Rhumbline Advisers Cuts Position in USANA Health Sciences, Inc. (NYSE:USNA)

Rhumbline Advisers reduced its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 26.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 36,305 shares of the company's stock after selling 13,085 shares during the period. Rhumbline Advisers owned 0.19% of USANA Health Sciences worth $979,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Principal Financial Group Inc. increased its stake in shares of USANA Health Sciences by 2.8% during the 4th quarter. Principal Financial Group Inc. now owns 53,603 shares of the company's stock worth $1,924,000 after purchasing an additional 1,480 shares during the last quarter. Amundi boosted its position in USANA Health Sciences by 85.3% during the fourth quarter. Amundi now owns 4,872 shares of the company's stock valued at $170,000 after buying an additional 2,243 shares during the period. Pzena Investment Management LLC boosted its holdings in shares of USANA Health Sciences by 3.6% during the fourth quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company's stock worth $39,015,000 after purchasing an additional 37,466 shares during the period. Royce & Associates LP boosted its holdings in shares of USANA Health Sciences by 17.4% during the fourth quarter. Royce & Associates LP now owns 38,914 shares of the company's stock worth $1,397,000 after purchasing an additional 5,771 shares during the period. Finally, Quantbot Technologies LP bought a new position in USANA Health Sciences in the fourth quarter worth about $132,000. 54.25% of the stock is currently owned by institutional investors and hedge funds.

USANA Health Sciences Trading Down 0.8%

USNA stock traded down $0.25 on Monday, hitting $30.30. The company had a trading volume of 187,103 shares, compared to its average volume of 138,116. USANA Health Sciences, Inc. has a 12-month low of $23.10 and a 12-month high of $48.85. The stock's 50-day simple moving average is $28.72 and its 200 day simple moving average is $30.70. The stock has a market cap of $564.19 million, a price-to-earnings ratio of 16.65, a P/E/G ratio of 0.98 and a beta of 0.63.

USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The company reported $0.73 EPS for the quarter, beating the consensus estimate of $0.70 by $0.03. USANA Health Sciences had a return on equity of 8.94% and a net margin of 3.98%. The business had revenue of $249.54 million for the quarter, compared to the consensus estimate of $243.08 million. During the same period in the previous year, the business earned $0.86 earnings per share. Research analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on USNA shares. DA Davidson reduced their price target on shares of USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating for the company in a research report on Thursday, February 27th. Wall Street Zen raised shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a research report on Thursday, May 22nd.

Insider Transactions at USANA Health Sciences

In other news, COO Walter Noot sold 6,291 shares of the company's stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total transaction of $190,554.39. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO G Doug Iiekking sold 4,548 shares of the business's stock in a transaction that occurred on Friday, May 9th. The shares were sold at an average price of $29.61, for a total value of $134,666.28. The disclosure for this sale can be found here. Over the last three months, insiders have sold 12,013 shares of company stock valued at $360,149. 0.63% of the stock is currently owned by insiders.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.